Compass Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2024 | 2 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2024 | 2 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2024 | 6 | -$0.15 | -$0.07 | -$0.10 |
| Q1 2025 | 1 | -$0.08 | -$0.07 | -$0.08 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Compass Therapeutics, Inc. Earnings Date And Information
Compass Therapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.08 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Compass Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.33 diluted earnings per share) and currently has a price-to-earnings ratio of -4.15. Compass Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Compass Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2024 | Q1 2024 | -$0.11 | -$0.08 | 0.03 | $0 | $0 |
| 03/21/2024 | Q4 2023 | -$0.09 | -$0.11 | -0.02 | $2.84 M | |
| 11/09/2023 | Q3 2023 | -$0.11 | -$0.08 | 0.03 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.08 | -$0.09 | -0.01 | $0 | |
| 05/04/2023 | Q1 2023 | -$0.11 | -$0.05 | 0.06 | $0 | |
| 03/15/2023 | Q4 2022 | -$0.11 | -$0.10 | 0.01 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.11 | -$0.11 | 0 | $0 | |
| 08/01/2022 | Q2 2022 | -$0.09 | -$0.08 | 0.01 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.14 | -$0.07 | 0.07 | $0 | |
| 03/18/2022 | Q4 2021 | -$0.25 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.12 | -$0.10 | 0.02 | $0 | |
| 08/16/2021 | Q2 2021 | -$1.07 | $0 | |||
| 04/30/2021 | Q1 2021 | -$0.14 | $0 | |||
| 03/05/2021 | Q4 2020 | -$0.14 | $0 | |||
| 11/09/2020 | Q3 2020 | -$0.15 | $0 | |||
| 08/13/2020 | Q2 2020 | -$0.11 | $0 | |||
| 06/08/2020 | Q1 2020 | -$0.12 | $0 | |||
| 02/13/2020 | Q4 2019 | -$0.11 | $0 | |||
| 11/13/2019 | Q3 2019 | -$0.16 | $0 | |||
| 08/13/2019 | Q2 2019 | -$0.17 | $0 |
Compass Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Compass Therapeutics, Inc.'s earnings date?
Compass Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
-
Did Compass Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Compass Therapeutics, Inc. (:CMPX) reported $-0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.03.
-
How can I listen to Compass Therapeutics, Inc.'s earnings conference call?
The conference call for Compass Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Compass Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Compass Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Compass Therapeutics, Inc. generate each year?
Compass Therapeutics, Inc. (:CMPX) has a recorded net income of $0. Compass Therapeutics, Inc. has generated $-0.33 earnings per share over the last four quarters.
-
What is Compass Therapeutics, Inc.'s price-to-earnings ratio?
Compass Therapeutics, Inc. (:CMPX) has a price-to-earnings ratio of -4.15 and price/earnings-to-growth ratio is 0.33.
